The CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the CHRNA4 gene, which have been linked to nocturnal frontal lobe epilepsy type 1 (ENFL1). This form of epilepsy is characterized by seizures that predominantly occur during sleep, affecting the frontal lobes of the brain. The CHRNA4 gene plays a crucial role in the regulation of neurotransmitter release in the brain, and mutations in this gene can disrupt normal neurological functions, leading to the development of epilepsy.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is essential for individuals exhibiting symptoms of nocturnal frontal lobe epilepsy or those with a family history of the condition. By analyzing a sample of the patient’s DNA, the test can detect specific genetic alterations in the CHRNA4 gene that are responsible for the disorder. This information is invaluable for accurate diagnosis, allowing healthcare providers to tailor treatment plans more effectively and offer genetic counseling to affected families.

The cost of the CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers crucial insights into the genetic basis of the condition, enabling better management and understanding of the disease. It represents a critical step towards personalized medicine in the management of epilepsy, providing patients and their families with hope for more targeted and effective treatments.